201 related articles for article (PubMed ID: 11967627)
1. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
Verheyden SL; Hadfield J; Calin T; Curran HV
Psychopharmacology (Berl); 2002 Apr; 161(1):23-31. PubMed ID: 11967627
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
[TBL] [Abstract][Full Text] [Related]
3. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
Curran HV; Travill RA
Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
[TBL] [Abstract][Full Text] [Related]
4. The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings.
Hoshi R; Bisla J; Curran HV
Drug Alcohol Depend; 2004 Dec; 76(3):297-304. PubMed ID: 15561480
[TBL] [Abstract][Full Text] [Related]
5. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
Verheyden SL; Henry JA; Curran HV
Hum Psychopharmacol; 2003 Oct; 18(7):507-17. PubMed ID: 14533132
[TBL] [Abstract][Full Text] [Related]
6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
7. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.
Curran HV; Rees H; Hoare T; Hoshi R; Bond A
Psychopharmacology (Berl); 2004 May; 173(3-4):425-33. PubMed ID: 14735288
[TBL] [Abstract][Full Text] [Related]
8. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
9. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
Huxster JK; Pirona A; Morgan MJ
J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Falck RS; Wang J; Carlson RG
J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
[TBL] [Abstract][Full Text] [Related]
11. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
12. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
13. Executive function in abstinent MDMA ('ecstasy') users.
Zakzanis KK; Young DA
Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
15. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
16. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
17. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
Butler GK; Montgomery AM
Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
[TBL] [Abstract][Full Text] [Related]
18. A review of the acute subjective effects of MDMA/ecstasy.
Baylen CA; Rosenberg H
Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
[TBL] [Abstract][Full Text] [Related]
19. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Milani RM; Parrott AC; Schifano F; Turner JJ
Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
[TBL] [Abstract][Full Text] [Related]
20. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
